Zentalis Pharmaceuticals' chief medical officer acquires $45,656 in stock
Officer of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL), recently purchased 20,000 shares of the company's common stock. The shares were acquired at a price of $2.2828 each, totaling $45,656.
Le Lézard2 分钟
InterCure Names Alexander Rabinovich as Chairman Replacing Ehud Barak
InterCure Ltd. (dba Canndoc) ("InterCure" or the "Company"), announces today that Mr. Ehud Barak will step down as Chairman of the board of directors of the Company (the "Board"), effective February ...
fnarena33 分钟
Behring Margin Outlook Still Main Game For CSL
A weak vaccine result dragged on CSL's H1 result but analysts focus on an improving plasma product margin and solid growth forecasts in maintaining positive views ...
MIT Technology Review4 分钟
Now read the rest of The Algorithm
The 2025 edition will be published in January. Here’s what won’t be on it. AI advances are rapidly speeding up the process of training robots, and helping them do new tasks almost instantly. Making ...
The Lancet2 分钟
Patient with cystic fibrosis not diagnosed until age 23 years now treated with the new ...
The effect of cystic fibrosis on many organs and the frequent lung infections means that it is mostly diagnosed in childhood. Somehow, for Verônica Stasiak Bednarczuk, that diagnosis did not arrive ...
White House rails against AP using term ‘Gulf of Mexico’ after Trump renames it: Live ...
Donald Trump said he had a “highly productive” call with Russian President Vladimir Putin on Wednesday. He provided a lengthy ...